About
Letronat 2.5mg Tablet is an anticancer drug that contains the active ingredient letrozole and belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts
Inform your physician if you have not attained menopause yet, as this medicine does not work for premenopausal women. Since this medicine tends to reduce the levels of female reproductive hormones, it is not advised for menstruating women as it is related to causing fertility issues. It is advised to keep track of your cholesterol levels as this medicine tends to elevate cholesterol levels. Letronat 2.5mg Tablet could also decrease bone mineral density. Hence, discuss with your physician and consider monitoring your bone parameters regularly. It is advised to use effective birth control during the treatment and at least 3 weeks after the last dose.
- First‑ and second‑line treatment for postmenopausal women with hormone receptor‑positive breast cancer
- Treatment for advanced breast cancer of unknown origin in postmenopausal women
- Supportive therapy for postmenopausal women with early breast cancer
- Extended supportive therapy for postmenopausal women with early breast cancer who have already received other anticancer medications
Directions for use
Side effects
- Decreased red blood cells
- Decreased bone mineral density
- Fluid build‑up in the lungs
- Swelling in the face, eyes, feet, or legs
- Hot sweats and excessive sweating
- Hypercholesterolaemia (high cholesterol)
- Hypertension
- Heart palpitations
- Breathing difficulty
- Dizziness, tiredness, and sleepiness
- Loss of appetite
- Nausea and vomiting
- Constipation
- Diarrhoea
- Muscle pain, bone pain, and joint stiffness
- Arthralgia
Safety Measures
Alcohol - Consuming alcohol during treatment with Lupride Depot 22.5mg Injection may increase the risk of bone thinning (osteoporosis). Use caution and consult your doctor for further guidance.
Pregnancy - Alcohol consumption is not recommended during treatment with Letronat 2.5mg Tablet, as it may lead to serious complications.
BreastFeeding - Letronat 2.5mg Tablet is highly unsafe during pregnancy, as it may harm the unborn baby. Consult your doctor about effective contraceptive methods to use during treatment. Inform your physician if you are pregnant, think you may be pregnant, or are planning to become pregnant.
Liver - Lupride Depot 22.5mg Injection should be used with caution in patients with liver impairment. Inform your doctor about any existing liver conditions before starting treatment.
Kidney - There is limited information on the use of Lupride Depot 22.5mg Injection in patients with kidney disease. Consult your doctor for advice before starting treatment.
Disclaimer
Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!